Impact of Vedolizumab on Bowel Urgency in Ulcerative Colitis: Post Hoc Analysis of the GEMINI 1, VISIBLE 1, and VARSITY Trials
Angelina E Collins, Thais Gift, Edward Kim, Ian Robinson · 2026
Read Impact of Vedolizumab on Bowel Urgency in Ulcerative Colitis: Post Hoc Analysis of the GEMINI 1, VISIBLE 1, and VARSITY Trials by Angelina E Collins, Thais Gift, Edward Kim, Ian Robinson (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13634436.txt.
Description
Angelina Collins, Thais Gift, Edward Kim, and Ian Robinson analyze the effect of vedolizumab on bowel urgency in ulcerative colitis, in a research paper from 2026. Urgency, the sudden need to reach a toilet, is among the most burdensome symptoms of the bowel disease. The drug is used for moderate to severe cases, but its effect on urgency had not been isolated.
Data pool more than twelve hundred patients from three phase three trials of the drug against placebo. Three questionnaire items form an urgency score, and full resolution means no symptoms on all three. Outcomes at one year compare score change and resolution rates. Groups split by past drug exposure and disease activity add detail.
Catalog record
| CREATOR | Angelina E Collins, Thais Gift, Edward Kim, Ian Robinson |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |